ADIA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 10, 2025
Report Source: 2024 3rd Quarter Report
A
Adia Nutrition Inc. Stock Analysis ADIA
Adia Nutrition, Inc. is engaged in the creation of probiotics. The company is headquartered in Winter Park, Florida. The company went IPO on 2004-03-23. The Company’s divisions include supplement division and medical division. The supplement division provides organic supplements. The medical division establishes clinics that specialize in stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Adia Med of Winter Park, LLC, its subsidiary, operates clinic to perform treatments, and Adia Labs, LLC, its subsidiary, procures and sells the products relating to these procedures. Adia Med is conducting a nationwide rollout of satellite locations offering Umbilical Cord Stem Cell (UCB-SC) and exosome treatments, like AdiaVita from Adia Labs LLC, with at least 100 million stem cells and three trillion exosomes per unit. These therapies address chronic inflammation, autoimmune disorders, and orthopedic issues. The firm has approximately 18% equity position in Cement Factory, LLC.
Read More Adia Nutrition Inc (ADIA) Chart
Key Statistics of Adia Nutrition Inc (ADIA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.16Volume
2676.00P/E Ratio (TTM)
-52 Week Range
Market Cap
140.00KAvg. Volume
5472.22Dividend Yield
-Financial Metrics & Statements of Adia Nutrition Inc (ADIA)
FAQ's for Adia Nutrition Inc (ADIA)
- According to Musaffa’s Shariah screening methodology, Adia Nutrition Inc (ADIA) is currently classified as NOT HALAL as of February 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.